Stein Kaasa

Stein Kaasa's AcademicInfluence.com Rankings

Stein Kaasa

Philosophy

#4134

World Rank

#6534

Historical Rank

Logic

#1665

World Rank

#2475

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Stein Kaasa Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stein Kaasa's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Definition and classification of cancer cachexia: an international consensus. (2011) (3613)
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. (1998) (2511)
Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. (2011) (1889)
ESPEN guidelines on nutrition in cancer patients. (2017) (1659)
A classification of chronic pain for ICD-11 (2015) (1584)
Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11) (2019) (1059)
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. (2012) (1010)
Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. (1998) (927)
Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project (2004) (777)
The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. (1994) (773)
Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. (1999) (767)
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. (2000) (704)
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. (1998) (661)
Oxford Textbook of Palliative Medicine (2011) (649)
Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. (2005) (599)
Short Form 36 (SF-36) health survey: normative data from the general Norwegian population (1998) (584)
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. (1998) (572)
Fatigue in the general Norwegian population: normative data and associations. (1998) (561)
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis (1993) (501)
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. (2006) (499)
Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. (2002) (448)
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. (2002) (425)
Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. (1994) (408)
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. (1998) (407)
Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. (1998) (402)
The IASP classification of chronic pain for ICD-11: chronic neuropathic pain (2019) (389)
The European Association for Palliative Care. (2002) (388)
Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. (1992) (377)
Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. (2016) (374)
Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. (1995) (374)
The 118 A > G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease (2004) (367)
The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. (1995) (339)
Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). (1998) (338)
Integration of oncology and palliative care: a Lancet Oncology Commission. (2018) (335)
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients (2005) (325)
A Prospective Study of Quality of Life in Head and Neck Cancer Patients. Part II: Longitudinal Data (2001) (317)
Episodic (breakthrough) pain (2002) (315)
A palliative-care intervention and death at home: a cluster randomised trial (2000) (315)
Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial (1999) (306)
Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review (2012) (306)
Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. (1994) (302)
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene (2007) (296)
The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. (2002) (292)
Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). (1998) (291)
Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. (2009) (286)
Fatigue in palliative care patients — an EAPC approach (2008) (273)
A Prospective Study of Quality of Life in Head and Neck Cancer Patients. Part I: At Diagnosis (2001) (268)
Quality of life in palliative cancer care: results from a cluster randomized trial. (2001) (257)
Health care providers underestimate symptom intensities of cancer patients: A multicenter European study (2010) (254)
Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. (1998) (249)
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. (1998) (249)
Quality of life in palliative care: principles and practice (2003) (247)
ESPEN practical guideline: Clinical Nutrition in cancer. (2021) (232)
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. (2014) (231)
A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients (1999) (231)
Physical exercise for cancer patients with advanced disease: a randomized controlled trial. (2011) (216)
Psychological distress in head and neck cancer patients 7-11 years after curative treatment. (1995) (212)
Hodgkin's disease survivors more fatigued than the general population. (1999) (205)
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. (2011) (203)
Which patients with cancer die at home? A study of six European countries using death certificate data. (2010) (203)
The effect of a physical exercise program in palliative care: A phase II study. (2006) (202)
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer (2017) (198)
Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA). (2014) (187)
European Society for Medical Oncology (ESMO) position paper on supportive and palliative care (2018) (182)
Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients (2011) (181)
Cluster-randomized trials (2002) (180)
Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. (1998) (176)
Family satisfaction with end-of-life care for cancer patients in a cluster randomized trial. (2002) (175)
Physical exercise results in the improved subjective well-being of a few or is effective rehabilitation for all cancer patients? (2004) (175)
Reduced Mortality in Treating Acutely Sick, Frail Older Patients in a Geriatric Evaluation and Management Unit. A Prospective Randomized Trial (2002) (171)
Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. (2004) (167)
Malnutrition and food intake in relation to quality of life in head and neck cancer patients (1998) (167)
Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review. (2013) (167)
Population-based study of dying in hospital in six European countries (2008) (166)
Referral criteria for outpatient specialty palliative cancer care: an international consensus. (2016) (165)
A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation (2004) (162)
Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer (2015) (162)
Psychological distress in cancer patients with advanced disease. (1993) (162)
Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases. (2006) (158)
Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors--results from a pilot study. (2003) (156)
Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain (2008) (155)
Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool (2002) (154)
Assessment and classification of cancer breakthrough pain: A systematic literature review (2010) (151)
Cancer patients use of nonproven therapy: a 5-year follow-up study. (1998) (151)
Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. (1989) (148)
Fatigue and psychiatric morbidity among Hodgkin's disease survivors. (2000) (145)
Prognostic Factors in Patients with Advanced Cancer: A Comparison of Clinicopathological Factors and the Development of an Inflammation-Based Prognostic System (2013) (145)
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy (2002) (141)
Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. (2009) (138)
Late medical complications and fatigue in Hodgkin's disease survivors. (2001) (136)
The EORTC Modular Approach to Quality of Life Assessment in Oncology (1994) (135)
Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. (2014) (134)
Integration of oncology and palliative care: a systematic review. (2015) (134)
Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network (2005) (132)
The European Organisation for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update. (1995) (130)
Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics (2001) (125)
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial (2018) (124)
The IASP classification of chronic pain for ICD-11: chronic cancer-related pain (2019) (122)
A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPCRC cachexia guidelines project (2012) (121)
Clinical pharmacology of methadone for pain (2008) (118)
Associations between recreational exercise and chronic pain in the general population: Evidence from the HUNT 3 study (2011) (117)
Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. (1998) (116)
Neuropathic cancer pain: Prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative–Computerised Symptom Assessment study (2013) (113)
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients (2003) (113)
Measurement of health‐related quality of life in multiple myeloma (1996) (112)
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. (2013) (111)
Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response. (2016) (109)
Symptom assessment in palliative care: a need for international collaboration. (2008) (109)
Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. (2010) (107)
Health Status of People with Epilepsy Compared with a General Reference Population (2000) (106)
Indicators of integration of oncology and palliative care programs: an international consensus. (2015) (105)
Chronic non‐malignant pain patients report as poor health‐related quality of life as palliative cancer patients (2007) (105)
Genetic variability and clinical efficacy of morphine (2005) (103)
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study (2011) (103)
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients (2003) (102)
The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. (2001) (102)
Depression assessment and classification in palliative cancer patients: a systematic literature review (2009) (102)
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. (1999) (101)
Prospective, longitudinal quality-of-life study of patients with head and neck cancer: a feasibility study including the EORTC QLQ-C30. (1997) (99)
Estimating the prevalence of chronic pain: Validation of recall against longitudinal reporting (the HUNT pain study) (2012) (97)
Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors. (1997) (96)
Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial (2003) (96)
Pain assessment tools: is the content appropriate for use in palliative care? (2006) (93)
Pain assessment tools in palliative care: an urgent need for consensus (2008) (92)
The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up (2003) (91)
Methodological and structural challenges in palliative care research: how have we fared in the last decades? (2006) (90)
The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors (2003) (88)
Attitudes towards, and wishes for, euthanasia in advanced cancer patients at a palliative medicine unit (2005) (88)
Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. (1999) (88)
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. (2016) (88)
The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation (1999) (87)
Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine (2000) (87)
Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients. (2014) (87)
Symptomatic treatment versus combination chemotherapy for patients with extensive non‐small cell lung cancer (1991) (86)
A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project (2016) (85)
European Palliative Care Research Collaborative pain guidelines: Opioid switching to improve analgesia or reduce side effects. A systematic review (2011) (85)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling (2017) (85)
High level of fatigue in lymphoma patients treated with high dose therapy. (2000) (84)
The length of consent documents in oncological trials is doubled in twenty years. (2009) (83)
The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). (2016) (83)
Place of death: hospital-based advanced home care versus conventional care (2004) (83)
Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study (2005) (82)
Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review (2013) (82)
Classification of pain in cancer patients – a systematic literature review (2009) (81)
Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? (1999) (81)
Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review. (2014) (81)
Development of an EORTC questionnaire module to be used in health‐related quality‐of‐life assessment for patients with multiple myeloma (1999) (79)
Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. (1995) (79)
Quality-of-life assessment in palliative care. (2002) (78)
Disclosing the cancer diagnosis: the patients' experiences. (1997) (78)
Measuring quality of palliative care: Psychometric properties of the FAMCARE Scale (2003) (78)
Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. (2011) (77)
A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group. (1990) (76)
Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysis. (2013) (76)
Prevalence of pain in hospitalised cancer patients in Norway: a national survey (2007) (76)
Evolving classification systems for cancer cachexia: ready for clinical practice? (2010) (75)
Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. (2011) (74)
Does use of alternative medicine predict survival from cancer? (2003) (74)
A framework for generalizability in palliative care. (2009) (74)
The EORTC Core Quality-of-Life Questionnaire: Interim Results of an International Field Study * (2021) (73)
Prognostic factors and survival in a heterogeneous sample of cancer patients. (1996) (73)
Factors affecting grief reactions in close family members to individuals who have died of cancer. (2001) (72)
Norwegian reference values for the Short-Form Health Survey 36: development over time (2017) (72)
The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. (1995) (72)
Quality of life in adult cancer patients treated with bone marrow transplantation--a review of the literature. (1995) (71)
Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: Three peas in a pod? – analysis from a multicenter cross sectional study (2014) (71)
Quality of life of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire. (1988) (71)
Assessing physical functioning: a systematic review of quality of life measures developed for use in palliative care (2007) (71)
The first year of grief and bereavement in close family members to individuals who have died of cancer (2001) (71)
From "Breakthrough" to "Episodic" Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Toward a Common Terminology and Classification of Transient Cancer Pain Exacerbations. (2016) (70)
Experiences with the Implementation of Computerized Tools in Health Care Units: A Review Article (2008) (70)
Chronic pain: One year prevalence and associated characteristics (the HUNT pain study) (2013) (70)
Are palliative cancer patients willing and able to participate in a physical exercise program? (2005) (68)
Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. (1997) (68)
Effect of interferon on the health‐related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan–prednisone to melphalan–prednisone + α‐interferon (1996) (68)
Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy--evaluation of long-term effects of diagnosis and treatment. (2000) (67)
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial. (1999) (65)
Long-term somatic side-effects and morbidity in testicular cancer patients. (1990) (65)
Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network. (2018) (64)
Methods for assessment of cognitive failure and delirium in palliative care patients: implications for practice and research (2004) (64)
Pain and quality of life among residents of Norwegian nursing homes. (2010) (64)
Fatigue. Measures and relation to pain (1999) (63)
Self-reported satisfaction with life and physical health in long-term cancer survivors and a matched control group. (1995) (63)
Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain. (2011) (63)
Longitudinal Associations between Exercise and Pain in the General Population - The HUNT Pain Study (2013) (63)
Using death certificate data to study place of death in 9 European countries: opportunities and weaknesses (2007) (62)
Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning. (2010) (62)
The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire. (2018) (61)
Assessment and classification of cancer pain (2009) (60)
Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor. (2001) (60)
Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients (2003) (59)
The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer (2017) (59)
Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. (2000) (59)
Psychosocial well-being in testicular cancer patients. (1991) (59)
Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: An EPCRC opioid guidelines project (2011) (58)
Expert conference on cancer pain assessment and classification—the need for international consensus: working proposals on international standards (2011) (57)
Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSA. (2012) (57)
Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients (2010) (57)
Which cancer patients die in nursing homes? Quality of life, medical and sociodemographic characteristics (2003) (57)
Integration of oncology and palliative care. (2018) (56)
Doloplus-2, a valid tool for behavioural pain assessment? (2007) (56)
Effects on cancer patients' health-related quality of life after the start of morphine therapy. (2000) (56)
Which domains should be included in a cancer pain classification system? Analyses of longitudinal data (2012) (56)
Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain. (2010) (55)
Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. (2013) (55)
Which mini-mental state exam items can be used to screen for delirium and cognitive impairment? (2005) (54)
Measurement of quality of life in clinical trials. (1992) (54)
Barriers to and facilitators for implementing quality improvements in palliative care – results from a qualitative interview study in Norway (2016) (54)
The Norwegian Doloplus-2, a tool for behavioural pain assessment: translation and pilot-validation in nursing home patients with cognitive impairment (2005) (54)
Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference? (2008) (54)
Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). (2005) (54)
The Brief Pain Inventory: Pain's Interference With Functions Is Different in Cancer Pain Compared With Noncancer Chronic Pain (2008) (53)
Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations (2011) (53)
Palliative care in Norway: a national public health model. (2007) (53)
Health-related quality of life during the last three months of life in patients with advanced cancer (2009) (53)
Validation of a quality of life questionnaire for use in clinical trials for treatment of patients with inoperable lung cancer. (1988) (53)
Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit (2002) (52)
Patient demographics and centre description in European palliative care units (2007) (52)
Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial. (2009) (52)
Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: A prospective survey in 300 adult cancer patients (2003) (52)
Pain in patients living in Norwegian nursing homes (2009) (51)
The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis (2017) (51)
Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain. (2007) (51)
Does social support from family and friends work as a buffer against reactions to stressful life events such as terminal cancer? (2007) (50)
Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken Scaling Model (2004) (49)
Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review (2011) (49)
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss (2016) (48)
Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast G (2003) (47)
Palliative care research. (2001) (47)
Inadequate symptom control in advanced cancer patients across Europe (2010) (46)
How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial. (2011) (46)
Toxicity, physical function and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus radiotherapy). (1988) (46)
Clinical priorities, barriers and solutions in end-of-life cancer care research across Europe. Report from a workshop. (2010) (45)
Neuropsychological evaluation of patients with inoperable non-small cell lung cancer treated with combination chemotherapy or radiotherapy. (1988) (45)
The European Cancer Patient’s Bill of Rights, update and implementation 2016 (2016) (44)
Depression in advanced cancer--assessment challenges and associations with disease load. (2015) (44)
Palliative care research--priorities and the way forward. (2008) (43)
Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study (2006) (43)
Health-related quality of life (HRQOL) in family members of cancer victims: results from a longitudinal intervention study in Norway and Sweden (2004) (43)
Development of computerized adaptive testing (CAT) for the EORTC QLQ-C30 physical functioning dimension (2011) (43)
A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer (2018) (43)
Automatic referral to standardize palliative care access: an international Delphi survey (2017) (43)
The European Association for Palliative Care basic dataset to describe a palliative care cancer population: Results from an international Delphi process (2014) (42)
Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer (2016) (42)
Driving functions in a video simulator in chronic non-malignant pain patients using and not using codeine. (2011) (42)
Intranasal midazolam: a comparison of two delivery devices in human volunteers (2006) (41)
Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring. (2011) (41)
Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study (2014) (40)
Compliance in quality of life data: a Norwegian experience. (1998) (40)
Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. (2016) (40)
Acute geriatric intervention increases the number of patients able to live at home. A prospective randomized study (2004) (40)
A multicenter study of attitudinal barriers to cancer pain management (2017) (40)
Development and course of chronic pain over 4 years in the general population: The HUNT pain study (2018) (39)
Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study (2019) (39)
Computer-Based Clinical Decision Support Systems and Patient-Reported Outcomes: A Systematic Review (2015) (39)
Quality of life during pelvic radiotherapy (1995) (39)
Attitudes toward informing the cancer patient--a survey of Norwegian physicians. (1996) (38)
A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer. (1988) (38)
Variable response to opioid treatment: any genetic predictors within sight? (2008) (38)
Deaths of children occurring at home in six European countries. (2010) (38)
Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study. (2006) (38)
Resilience for family carers of advanced cancer patients—how can health care providers contribute? A qualitative interview study with carers (2018) (38)
Genetic analysis of the murine μ opioid receptor: increased complexity of Oprm gene splicing (2004) (37)
Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway (2015) (37)
Content development for EUROPEAN GUIDELINES on the use of opioids for cancer pain: a systematic review and Expert Consensus Study. (2010) (36)
Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: A pilot randomized trial (2017) (36)
The Importance of Key Personnel and Active Management for Successful Implementation of Computer-Based Technology in Palliative Care: Results From a Qualitative Study (2008) (36)
Associations between physical activity and physical and mental health--a HUNT 3 study. (2011) (36)
P-selectin genotype is associated with the development of cancer cachexia (2012) (36)
Lack of concealment may lead to selection bias in cluster randomized trials of palliative care (2002) (35)
Multiple Loci Modulate Opioid Therapy Response for Cancer Pain (2011) (35)
Development of an item bank for computerized adaptive test (CAT) measurement of pain (2015) (35)
Starting Step III opioids for moderate to severe pain in cancer patients: Dose titration: A systematic review (2011) (34)
The Edmonton Classification System for Cancer Pain: comparison of pain classification features and pain intensity across diverse palliative care settings in eight countries. (2013) (34)
A first step in the development of an international self-report instrument for physical functioning in palliative cancer care: a systematic literature review and an expert opinion evaluation study. (2009) (34)
Euthanasia and physician-assisted suicide in Scandinavia — with a conceptual suggestion regarding international research in relation to the phenomena (2002) (34)
“The healthy me appears”: Palliative cancer patients' experiences of participation in a physical group exercise program (2009) (34)
Psychosocial well-being of patients with inoperable non-small cell lung cancer. The importance of treatment- and disease-related factors. (1988) (33)
The Understanding of Informed Consent Information—Definitions and Measurements in Empirical Studies (2010) (33)
Methods for handling missing data in palliative care research (2006) (32)
Depressed patients with incurable cancer: Which depressive symptoms do they experience? (2013) (32)
Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? (2015) (32)
Depression-A Major Contributor to Poor Quality of Life in Patients With Advanced Cancer. (2017) (32)
Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group. (1996) (31)
Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial. (2018) (30)
Validation of Doloplus-2 among nonverbal nursing home patients - an evaluation of Doloplus-2 in a clinical setting (2010) (30)
Long term methadone for chronic pain: A pilot study of pharmacokinetic aspects (2007) (29)
Patients with advanced cancer and depression report a significantly higher symptom burden than non-depressed patients (2018) (29)
A systematic review of oxymorphone in the management of chronic pain. (2010) (29)
Cancer patients’ knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study (2018) (29)
Classification of neuropathic pain in cancer patients: A Delphi expert survey report and EAPC/IASP proposal of an algorithm for diagnostic criteria (2014) (29)
New proposals for the International Classification of Diseases-11 revision of pain diagnoses. (2012) (28)
Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study. (2005) (28)
Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma (2001) (28)
Spinal opioids in adult patients with cancer pain: A systematic review: A European Palliative Care Research Collaborative (EPCRC) Opioid Guidelines Project (2011) (28)
EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? (2006) (27)
A pan-European survey of research in end-of-life cancer care (2010) (27)
A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic (2014) (27)
Prognostic factors in patients with nasopharyngeal carcinoma. (1993) (27)
The influence of low fat, low lactose diet on diarrhoea during pelvic radiotherapy. (1992) (26)
Patients with problematic opioid use can be weaned from codeine without pain escalation (2010) (26)
Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids (2015) (26)
Self-report measurement of pain & symptoms in palliative care patients: a comparison of verbal, visual and hand scoring methods in Sub-Saharan Africa (2014) (25)
Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort. (2019) (25)
Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With Cachexia. (2017) (25)
Prospective, Longitudinal Quality-of-Life Study of Patients With Head and Neck Cancer: A Feasibility Study Including the EORTC QLQ-C30 (1997) (25)
The dimensionality of pain: Palliative care and chronic pain patients differ in their reports of pain intensity and pain interference (2011) (25)
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research (2016) (25)
Lung cancer patients' perceptions of informed consent documents. (2008) (25)
Feasibility and changes in symptoms and functioning following inpatient cancer rehabilitation (2012) (25)
Building up research in palliative care: an historical perspective and a case for the future. (2005) (25)
Randomised Trial of In-Hospital Geriatric Intervention: Impact on Function and Morale (2006) (24)
Spiritual healing among Norwegian hospitalised cancer patients and patients' religious needs and preferences of pastoral services. (1996) (24)
Comparisons of patient and physician assessment of pain-related domains in cancer pain classification: results from a large international multicenter study. (2014) (24)
Characteristics and quality of life of patients who choose home care at the end of life. (2008) (24)
Reduced short-term neuropsychological performance in patients with nonsmall-cell lung cancer treated with cisplatin and etoposide. (1988) (22)
Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients. (2012) (22)
The need to revise pain diagnoses in ICD-11 (2010) (22)
EORTC Quality of Life Questionnaire (2014) (22)
Computer-based assessment of symptoms and mobility in palliative care: feasibility and challenges. (2009) (22)
Opioids in pain management of mesothelioma and lung cancer patients (2013) (21)
Characteristics and implications of attrition in health-related quality of life studies in palliative care (2009) (21)
[Delirium in palliative care]. (2006) (21)
Assessment of quality of life in palliative care. (2001) (21)
A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients. (2009) (21)
Quality of life in clinical cancer trials: experience and perspective of the European Organization for Research and Treatment of Cancer. (1996) (21)
Palliative Thoracic Radiotherapy in Locally Advanced Non-small Cell Lung Cancer: Can Quality-Of-Life Assessments Help in Selection of Patients for Short- or Long-Course Radiotherapy? (2006) (21)
How are palliative care cancer populations characterized in randomized controlled trials? A literature review. (2014) (20)
Comprar Oxford Textbook of Palliative Medicine 4Ed | Russell K. Portenoy | 9780199693146 | Oxford University Press (2011) (20)
Radiotherapy for bone metastases: Practice in Norway 1997–2007. A national registry-based study (2013) (20)
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial. (2016) (20)
Efficacy and tolerability of intranasal fentanyl spray in cancer patients with breakthrough pain. (2015) (20)
Hodgkin's disease: quality of life in future trials. (1998) (19)
The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care Cancer symptom study. (2019) (19)
Late radiation effects to the rectum and anus after treatment for prostate cancer; validity of the LENT/SOMA score (2013) (19)
Quality of life in prostate cancer (1992) (19)
Feasibility and acceptance of electronic monitoring of symptoms and syndromes using a handheld computer in patients with advanced cancer in daily oncology practice (2014) (18)
Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory (2007) (18)
Psychometric Properties of the Norwegian Macnew Heart Disease Health-Related Quality of Life Inventory (2010) (18)
Multimodal nutrition/anabolic therapy for wasting conditions (2014) (18)
Introduction of low dose transdermal buprenorphine – Did it influence use of potentially addictive drugs in chronic non‐malignant pain patients? (2009) (18)
Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl (2015) (18)
Implementation of computerized technology in a palliative care unit (2009) (18)
Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study (2016) (18)
Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population – a cross-sectional study (2007) (17)
Measurement of physical activity in cancer survivors—a comparison of the HUNT 1 Physical Activity Questionnaire (HUNT 1 PA-Q) with the International Physical Activity Questionnaire (IPAQ) and aerobic capacity (2013) (17)
Sleep quality in hospitalized patients with advanced cancer: an observational study using self-reports of sleep and actigraphy (2019) (17)
Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain (2013) (17)
Fatigue and cancer—prevalence, correlates and measurement (1998) (17)
Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia (2019) (16)
The CARES‐SF used for prospective assessment of health‐related quality of life after stem cell transplantation (2003) (16)
Development and testing of a computerized pain body map in patients with advanced cancer. (2014) (16)
Renal function and symptoms/adverse effects in opioid‐treated patients with cancer (2015) (16)
Supporting carers: health care professionals in need of system improvements and education - a qualitative study (2019) (16)
Communicating with and treating cancer patients: how does the use of non-proven therapies and patients' feeling of mental distress influence the interaction between the patient and the hospital staff. (1997) (15)
Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients (2012) (15)
A randomised, open-label trial of a Multimodal Intervention (Exercise, Nutrition and Anti-inflammatory Medication) plus standard care versus standard care alone to prevent / attenuate cachexia in advanced cancer patients undergoing chemotherapy. (2015) (15)
Editorial: Palliative care research – time to intensify international collaboration (2008) (15)
Changes in medication use in a cohort of patients with advanced cancer: The international multicentre prospective European Palliative Care Cancer Symptom study (2018) (15)
How are patient populations characterized in studies investigating depression in advanced cancer? Results from a systematic literature review. (2014) (15)
Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer (2016) (15)
A prospective study examining cachexia predictors in patients with incurable cancer (2019) (14)
Neuropathic pain: clinical classification and assessment in patients with pain due to cancer (2020) (14)
Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity. (2010) (14)
Pain in elderly hospitalized cancer patients with bone metastases in Norway. (2008) (14)
Measurement of health-related quality of life during chemotherapy – the importance of timing (2017) (14)
Update on cancer pain guidelines. (2009) (14)
Palliative Cancer Care Research (2010) (14)
Is it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart (2016) (13)
Challenges related to palliative care. (2011) (13)
Early integration of palliative care-new evidence and old questions. (2018) (13)
Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer. (2016) (13)
Using quality of life assessment methods in patients with advanced cancer: a clinical perspective. (1995) (13)
The use of antidepressants in patients with advanced cancer—results from an international multicentre study (2014) (13)
Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study (2004) (12)
How to evaluate the effect of pain treatments in cancer patients: Results from a longitudinal outcomes and endpoint Italian cohort study (2013) (12)
[Self-evaluation of knowledge and competence with regard to the treatment of pain]. (1998) (12)
Lack of association between genetic variability and multiple pain-related outcomes in a large cohort of patients with advanced cancer: the European Pharmacogenetic Opioid Study (EPOS) (2012) (12)
Sleep quality with WHO Step III opioid use for cancer pain (2018) (12)
Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain (2012) (12)
Letter to the Editor (2006) (11)
COMBAT study – Computer based assessment and treatment – A clinical trial evaluating impact of a computerized clinical decision support tool on pain in cancer patients (2017) (11)
Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients (2011) (11)
Genetic clustering of European cancer patients indicates that opioid-mediated pain relief is independent of ancestry (2011) (11)
Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy induced emesis: a randomized, single-blind, multicentre study. The Ondansetron International Emesis Study Group. (1992) (11)
Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice. (2021) (11)
Improving the organization of palliative care by implementing quality indicators and national and setting-specific interventions: Study protocol of the IMPACT project (2014) (10)
The role of opioids in cancer progression: emerging experimental and clinical implications. (2016) (10)
Euthanasia and palliative care (2015) (10)
Interviews with patients with advanced cancer—another step towards an international cancer pain classification system (2012) (10)
Ipilimumab in a real‐world population: A prospective Phase IV trial with long‐term follow‐up (2021) (10)
Symptoms in the general Norwegian adult population - prevalence and associated factors (2020) (10)
Cancer pain research: Time to reset the strategy and the agenda (2011) (10)
[Is terminal sedation active euthanasia?]. (2000) (10)
[Genetic variation-- important for the clinical effect of opioids?]. (2005) (9)
Development and course of chronic widespread pain: The role of time and pain characteristics (the HUNT pain study). (2019) (9)
Elderly gynaecological cancer patients at risk for poor end of life care: a population-based study from the Swedish Register of Palliative Care (2020) (9)
Translating health. The International Quality of Life Assessment (IQOLA) project (1994) (9)
A pilot study of nasal fentanyl for patient controlled treatment of cancer pain. (2014) (9)
Chemotherapy in end-of-life care. (2017) (9)
The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain (2018) (9)
The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer (2016) (9)
The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses (2016) (9)
Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model (2020) (8)
Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer (2019) (8)
The European Union–not united in opioid use (2005) (8)
Treatment intention in hospitalized cancer patients in oncological wards in Norway: a national survey. (1996) (8)
Integration between Oncology and Palliative Care: A Plan for the Next Decade? (2017) (8)
[Specialised short-term wards in nursing homes--the Trondheim model]. (2005) (8)
Supportive care in cancer: new directions to achieve universal access to psychosocial, palliative, and end-of-life care (2018) (8)
[Palliative sedation to dying patients in Norway]. (2001) (8)
Development of EirV3: A Computer-Based Tool for Patient-Reported Outcome Measures in Cancer. (2017) (8)
The validity of average 8‐h pain intensity assessment in cancer patients (2010) (8)
An in-hospital clinical care pathway with integrated decision support for cancer pain management reduced pain intensity and needs for hospital stay (2019) (8)
Is Cancer Pain Control Improved by a Simple WHO Pain Analgesic Ladder Approach Combined With Tumor-Directed Treatment? (2016) (8)
Intention-to-treat analyses for randomised controlled trials in hospice/palliative care: the case for analyses to be of people exposed to the intervention. (2019) (8)
Anal carcinoma in mid-Norway 1970–2000 (2007) (8)
Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer (2016) (8)
Low‐dose transdermal buprenorphine – long‐term use and co‐medication with other potentially addictive drugs (2012) (8)
PATIENT VOICES, a project for the integration of the systematic assessment of patient reported outcomes and experiences within a comprehensive cancer center: a protocol for a mixed method feasibility study (2020) (7)
An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer (2019) (7)
The importance and pitfalls of correlational science in palliative care research (2012) (7)
Clinical and genetic factors related to cancer-induced bone pain and bone pain relief. (2014) (7)
Palliative Treatment of Cancer-Related Pain (2005) (7)
The characteristics of physical activity and gait in patients receiving radiotherapy in cancer induced bone pain. (2014) (7)
The effect of a low fat, low lactose diet on nutritional status during pelvic radiotherapy. (1993) (7)
Surgery for brain metastases—impact of the extent of resection (2022) (7)
[Patients with cancer-related pain and other chronic pain. Priorities and assessment]. (1996) (6)
PALLiON – PALLiative care Integrated in ONcology: study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care (2020) (6)
Pain management index (PMI)—does it reflect cancer patients’ wish for focus on pain? (2019) (6)
Cisplatin and etoposide (EP-regimen) is superior to cyclophosphamide, epirubicin, and vincristin (CEV-regimen) in small cell lung cancer: results from a randomized phase III trial with 5 years follow-up (2001) (6)
Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses (2018) (6)
Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study (2018) (6)
Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study (2018) (6)
Psychological distress after cancer cure (1997) (6)
Dose to penile bulb is not associated with erectile dysfunction 18 months post radiotherapy: A secondary analysis of a randomized trial (2018) (6)
Circadian distribution of oral opioid consumption in cancer patients. (2000) (5)
Quality assurance in the treatment of colorectal cancer : the EURECCA initiative (2014) (5)
Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial (2021) (5)
A prospective study examining cachexia predictors in patients with incurable cancer. (2018) (5)
Pain Assessment Tools in Palliative Cancer Care (2013) (5)
Consultant or Advisory Role: None Stock Ownership: Stephen McMorn, Endo Pharmaceuticals Honoraria: None Research Funding: None Expert Testimony: None Other Remuneration: None (2011) (5)
Usability testing of EirV3—a computer-based tool for patient-reported outcome measures in cancer (2018) (5)
Correction to: Norwegian reference values for the Short-Form Health Survey 36: development over time (2017) (5)
Classification algorithm for the ICD-11 chronic pain classification (CAL-CP): development and results from a preliminary pilot evaluation. (2021) (5)
Measurement error and research design: A note on the utility of panel data in quality of life research (1989) (5)
Depressive symptoms in the last days of life of patients with cancer: a nationwide retrospective mortality study (2015) (5)
A clinical description of chronic pain in a general population using ICD-10 and ICD-11 (The HUNT pain examination study). (2021) (4)
Psychosocial aspects of patients with lung cancer in controlled clinical trials. (1989) (4)
Integrated cancer control: the case for comprehensive cancer care networks (CCCN) (2017) (4)
Mild to moderate cognitive impairment does not affect the ability to self-report important symptoms in cancer patients: a prospective longitudinal multi-national study (EPCCS). (2020) (4)
Norway: development of palliative care. (2002) (4)
Food intake by Patient-Generated Subjective Global Assessment (PG-SGA) corresponds to energy and protein intake as well as weight change in patients with advanced cancer (2019) (4)
Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer (2021) (4)
Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma. (1991) (4)
Symptom assessment in palliative medicine. (2012) (4)
An international multicentre validation study of a pain classification system for cancer patients. (2010) (4)
Challenges and Learning Needs for Providers of Advanced Cancer Care: Focus Group Interviews with Physicians and Nurses (2020) (4)
Late Effects to the Rectum and Anus in Prostate Cancer Patients Randomized to Hormonal Therapy Versus Hormonal Therapy Plus Radiotherapy (2013) (4)
Identification of the predictors of cognitive impairment in patients with cancer in palliative care: a prospective longitudinal analysis (2017) (4)
[Hydration of patients with advanced cancer--is subcutaneous infusion a good solution?]. (1999) (3)
Incompatible: end-of-life care and health economics (2021) (3)
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer (2021) (3)
7.1 Research in palliative care (2009) (3)
Quality of Life in Patients With Advanced Cancer : Differential Association With Performance Status and Systemic In fl ammatory Response (2016) (3)
Chemotherapy During Pregnancy for Advanced Colon Cancer: A Case Report. (2020) (3)
Ondansetron in the prophylaxis of nausea and vomiting induced by cisplatin. (1990) (3)
Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial (2018) (3)
The Orkdal model: Development, implementation, and evaluation of collaboration between specialist and community care within cancer palliative care. (2014) (3)
Integration of general oncology and palliative care. (2013) (3)
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients (2020) (3)
[Symptoms assessment in cancer patients on admission to a hospital]. (2005) (3)
[Application of pupillometry and pupillary reactions in medical research]. (2005) (3)
Evidence-based guidelines for the use of opioid analgesics in the treatment of cancer pain: The 2011 EAPC Recommendations. (2012) (3)
[Use of opioids against severe cancer pain]. (2004) (3)
Which patients with cancer die at home in six ageing countries in Europe (2010) (3)
Radiation Therapy Did Not Induce Long-Term Changes in Rectal Mucosa: Results From the Randomized Scandinavian Prostate Cancer Group 7 Trial. (2016) (3)
Clinical predictors for analgesic response to radiotherapy in patients with painful bone metastases. (2021) (3)
Development of a computer-administered mobility questionnaire (2011) (3)
Spiritual quality of life in family carers of patients with advanced cancer—a cross-sectional study (2021) (3)
Surgery for brain metastases – real-world prognostic factors’ association with survival (2021) (3)
SECTION 20 Education and training in palliative medicine (2009) (2)
Integration of palliative care in oncology—the intersection of cultures and perspectives of oncology and palliative care (2022) (2)
What Do Cancer Patients and Members of Ethical Review Boards in Norway Consider Important Elements of Informed Consent Documents? (2014) (2)
Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway—Results from a Cluster Randomized Trial (2021) (2)
Author's Reply to: Integration between Oncology and Palliative Care: A Plan for the Next Decade? (2017) (2)
[Opioid switching and methadone in pain relief]. (2006) (2)
[Morphine or oxycodone tablets for pain?]. (2010) (2)
Clinical predictors for analgesic response to radiotherapy in patients with painful bone metastases (2019) (2)
[Sick leave while on a waiting list]. (1999) (2)
Global and regional partnerships to build evidence and capacity in supportive care (2018) (2)
1611TiPA novel multimodal treatment strategy for cancer cachexia; rationale and motivation for the MENAC (Multimodal – Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial (2017) (2)
[Use of alternative medicine among Norwegian hospitalized cancer patients]. (1997) (2)
Food choice and nutrient intake among patients on a low‐fat, low‐lactose diet: experience from a prospective randomized study (1999) (2)
EU policy recommendations for quality improvement in cancer after care at the community level. (2017) (2)
Corrigendum to “Dietary treatment of weight loss in patients with advanced cancer and cachexia: A systematic literature review” [Crit. Rev. Oncol./Hematol. 91 (2014) 210–221] (2015) (2)
Physical rehabilitation in patients with head and neck cancer: Impact on health‐related quality of life and suitability of a post‐treatment program (2020) (2)
Inpatient versus Outpatient Rehabilitation after Breast and Gynecological Cancers andndash; A Comparative Study (2013) (2)
Effect of opioid exposure on efficacy and tolerability of sublingual fentanyl and subcutaneous morphine for severe cancer pain episodes. Secondary analysis from a double-blind double-dummy, randomized trial. (2019) (2)
Calling for advocacy, education and public policy actions on pain control for patients with cancer in Africa (2020) (2)
Medical and Psychosocial Issues in Hodgkin’s Disease Survivors (2007) (2)
Specialist palliative care along the trajectory of illness (2021) (1)
A complex communication skills training program for physicians providing advanced cancer care – content development and barriers and solutions for implementation (2022) (1)
Cancer pain--progress and ongoing issues in Europe. (2009) (1)
Interaction between rifampicin and methadone. Authors' reply (2009) (1)
SECTION 10 The management of common symptoms and disorders (2009) (1)
Radiotherapy in palliative cancer care: Development and implementation (2012) (1)
Authors' Reply to Davies et al. (2016) (1)
BTcP: A physical, psychological and financial burden for the patient (2009) (1)
Role of morphine-6-glucuronide in morphine analgesia (2000) (1)
SECTION 15 Psychiatric, psychosocial, and spiritual issues in palliative medicine (2009) (1)
Integration of oncology and palliative care (PC): A systematic review. (2014) (1)
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-CAX24 (2017) (1)
The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial (2020) (1)
[Pain assessment in cognitively impaired elderly patients]. (2005) (1)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling (2017) (1)
10.7 Skin problems in palliative medicine (2009) (1)
Health care providers underestimate symptom intensities of cancer patients : A multicenter (2010) (1)
1441O Patient-reported outcomes in cancer patients newly diagnosed with brain metastases (2021) (1)
10.3 Weight loss in palliative medicine (2009) (1)
Palliative care in cancer: how to improve clinical research. (2010) (1)
severe cancer pain: An EPCRC opioid guidelines project Systematic review of the role of alternative application routes for opioid treatment for moderate to (2011) (1)
The Future of Oncology Palliative Care (2015) (1)
[Information and support to cancer patients. Experience from a course for young cancer patients at the Montebello Center]. (1992) (1)
Pharmacoeconomic Considerations in Treating Patients With Acute Leukaemia (1999) (1)
Sykefravær mens man står på venteliste (1999) (1)
[Teaching medical ethics: the Trondheim model]. (2004) (1)
PP090-SUN: Feasibility of Dietary Counseling to Attenuate Cachexia in Patients with Advanced Cancer (2014) (1)
The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (2016) (1)
10.1.7 Non-opioid analgesics (2009) (1)
Cancer patients’ knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study (2018) (1)
SECTION 1 Introduction to the fourth edition: facing the challenges of continuity and change (2009) (1)
Interview: Cancer pain management: the last decade and looking forward. (2013) (1)
Palliative cancer therapy during end of life at a regional cancer center in Norway in 2005 and 2009. (2012) (0)
Feasibility study of dietary counselling to attenuate cachexia in patients with advanced cancer. (2014) (0)
Erratum: Depressed patients with incurable cancer: Which depressive symptoms do they experience? (Palliative and Supportive Care (2013) DOI: 10.1017/S1478951512000909) (2013) (0)
Gender effect on the pharmacokinetics (PK) and pharmacodynamics (PD) of anamorelin (ANAM) in healthy volunteers and cancer patients with cachexia (2019) (0)
Psychosocial well being and clinical toxicity in a randomized controlled trial of patients with inoperable non-small cell lung cancer (limited disease) (1989) (0)
Integration of Supportive and Palliative Care into Oncology (2022) (0)
137 Topical Seminar Summary: PRACTICAL CONSIDERATIONS IN INTERVENTIONAL PAIN MANAGEMENT AT THE END OF LIFE (2006) (0)
SECTION 12 Palliative medicine in non-malignant disease (2009) (0)
1390PEfficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials (2017) (0)
Secondary Nutritional Impact Symptom Checklist (2018) (0)
ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey (2022) (0)
189 INVITED How to Improve Cancer Pain Control Through European Guidelines for Opioid Treatment and Cancer Pain Diagnosis (2011) (0)
Reply to C. A. Bull et al. (1988) (0)
SECTION 18 Palliative care in the home (2009) (0)
[Palliative medicine-- research and education in a new specialist field]. (2006) (0)
Inflammatory markers and radiotherapy response in patients with painful bone metastases. (2022) (0)
[Cancer patients should not feel pain]. (2005) (0)
Reply to S. McMorn et al (2011) (0)
High dose melphalan and autologous bone marrow transplantation in small cell lung cancer (1988) (0)
[Brain metastases from breast cancer. Effect of radiation therapy]. (1988) (0)
274 Treatment of cachexia-a preventive or symptomatic approach? (2009) (0)
SECTION 2 The worldwide status of palliative care (2009) (0)
1 BACKGROUND AND IMPLEMENTATION PLAN FOR THE EUROPEAN CANCER PATIENT’S BILL OF RIGHTS, 2016 (ARCHIVE) ECC Members (2017) (0)
SECTION 5 Ethical issues (2009) (0)
Trondheim behind the scenes (2012) (0)
836 COGNITIVE FUNCTIONING AND DRIVING IN A SIMULATOR AMONG CHRONIC PAIN PATIENTS WITH OR WITHOUT OPIOID TREATMENT (2009) (0)
Effect of low-lactose/low-fat diet during pelvic radiotherapy (1991) (0)
Ten-year overall and prostate cancer (PCa)-specific mortality in high-risk patients after high-dose-rate brachytherapy combined with external beam radiation therapy (HDR-BT/EBRT) compared with EBRT alone. (2017) (0)
What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study (2021) (0)
The oncologist’s role in delivering palliative care (2021) (0)
SECTION 19 The terminal phase (2009) (0)
[Food habits and cancer]. (1998) (0)
[Does use of alternative medicine aggravate the survival prognosis in cancer?]. (2003) (0)
Classification and assessment of cancer pain (2015) (0)
56 EPIDEMIOLOGY, ASSESSMENT AND CLASSIFICATION OF BREAKTHROUGH PAIN (BTP) (2009) (0)
[Personality and cancer]. (1989) (0)
Axonal Common Peroneal Nerve Palsy and Delayed Proximal Motor Radial Conduction Block Following Infliximab Treatment (2009) (0)
Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain (2012) (0)
Subjective symptom assessment in terminal care (2007) (0)
PD-117 Palliative thoracic radiotherapy (TRT) in locally advancednon-small cell lung cancer: Which patients should not be treated with short course TRT? (2005) (0)
Prevalence and predictors of cognitive dysfunction in opioid treated cancer patients (2010) (0)
1829P Are patient-reported symptoms and concerns affected by body mass index (BMI) and weight loss (WL) in patients with cancer cachexia? (2020) (0)
[From the hospice movement to palliative medicine]. (1995) (0)
[Palliative medicine]. (2001) (0)
More valuable than platinum : first-line pembrolizumab in advanced stage non-small-cell lung cancer (2017) (0)
[Nausea and vomiting during treatment with cytostatics]. (1991) (0)
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study (2011) (0)
cachexia guidelines project A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPCRC (2011) (0)
Summary of contents (2009) (0)
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative Care (2020) (0)
[Communication between cancer patients and their physicians. Knowledge and attitudes]. (1996) (0)
Reply (2009) (0)
SECTION 3 The challenge of palliative medicine (2009) (0)
Patient-centred care - is it possible? (2022) (0)
II Concurrent Sessions: Generic and Specific Applications of Quality of Life Instruments (2004) (0)
138 ONTOLOGICAL TREATMENT INCLUDING CHEMO‐and RADIOTHERAPY: INDICATIONS AND CONTRA INDICATIONS IN PATIENTS WITH SHORT LIFE EXPECTANCY (2006) (0)
[The cooperation between Helse Midt-Norge and NTNU supports clinical research]. (2005) (0)
Nutritional cancer care: Slowly evolving clinical practice reveals regional and professional HCP variability. (2018) (0)
PSYCHOSOCIAL ISSUES (2007) (0)
TheSystemic InflammatoryResponseand ItsRelationship toPainand OtherSymptoms inAdvancedCancer (2013) (0)
Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer (2022) (0)
SECTION 7 Research in palliative medicine (2009) (0)
evidence-based recommendations Management of opioid-induced nausea and vomiting in cancer patients : systematic review and (2011) (0)
518P Treatment outcome and prognostic factors after chemoradiotherapy for anal cancer (2020) (0)
Brain lesions in chronic fatigued survivors of Hodgkin's Lymphoma : An experimental study (2008) (0)
373P Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study (2021) (0)
1578PCurrent perspectives of healthcare providers on weight loss and supportive nutritional care in cancer patients (2017) (0)
Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway (2021) (0)
Usability testing of EirV3-a computer-based tool for patient reported outcome measures in cancer. (2018) (0)
Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study (2022) (0)
10.2 Gastrointestinal symptoms (2009) (0)
SECTION 13 Paediatric palliative medicine (2009) (0)
Opioid analgesics (2021) (0)
Radiation therapy in malignant spinal cord compression: what is the current knowledge on fractionation schedules? A systematic literature review (2012) (0)
Integration of oncology and palliative care: summary of the Lancet Oncology Commission Paper. (2020) (0)
Predication of cancer patients' survival by pain interference items is not the same as evidence that pain intensity is a survival predictor. (2008) (0)
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment (2022) (0)
[Investigation in suspected pulmonary tumor]. (2005) (0)
SECTION 14 Geriatric palliative medicine (2009) (0)
Hodgkin's D isease S urvivors M ore F atigued Than t he G eneral P opulation (1999) (0)
Bruk av pupillometri og pupillreaksjonar i medisinsk forsking (2005) (0)
SECTION 11 Issues in specific neoplastic disease (2009) (0)
Quality of life issues in the palliative care setting (1999) (0)
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients (2020) (0)
Depressed patients with incurable cancer: Which depressive symptoms do they experience?—ERRATUM (2013) (0)
SUN-P086: Weight Loss and Survival in Advanced Cancer in Relation to Inadequate Energy Intake (2016) (0)
Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial (2022) (0)
Self reported level of physical activity, smoking habits and sleep pattern among Hodgkin's disease survivors compared to the general population. (2006) (0)
High Protein Oral Nutritional Supplements Enable The Majority Of Cancer Patients To Meet ESPEN Protein Recommendations During Systemic Treatment (2023) (0)
review Starting Step III opioids for moderate to severe pain in cancer patients: Dose titration: A systematic (2011) (0)
1724P Personalised nutritional care during chemotherapy using survey on taste changes during chemotherapy: First experience from tertiary chemotherapy day care center in Northern India (2018) (0)
[High dose melphalan and autologous bone marrow transplantation in the treatment of small cell carcinoma of the lung]. (1988) (0)
Symptoms in the general Norwegian population - prevalence and associated factors (2020) (0)
Reply to O. Corli et al and M. Lucchesi et al. (2016) (0)
SECTION 6 Communication and palliative medicine (2009) (0)
OC-0500: Randomized controlled trial of Cone Beam CT IGRT in prostate cancer (2018) (0)
Research in palliative care (2021) (0)
[The specialist field of palliative medicine]. (2006) (0)
The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care Cancer symptom study. (2019) (0)
SECTION 9 Disease-modifying management in advanced cancer (2009) (0)
Cancer pain: Results of a prospective study on prognostic indicators of pain intensity including pain syndromes assessment (2022) (0)
IN REPLY: We appreciate the comments of Klepstad and Kaasa (2008) (0)
L1 Integration of oncology and palliative care: a review of its history and directions for the future (2023) (0)
Palliative Care in Europe (2010) (0)
Barriers and Facilitators When Implementing Electronic Patient-Reported Outcome Measures at a Municipal Cancer Care Unit: A Qualitative Study. (2022) (0)
Response to letter by Mercadante (2012) (0)
Reply to the letter to the editor 'Integration between oncology and palliative care: does one size fit all?' by Verna et al. (2016) (0)
Reply to “The pain, the oncologist” (2014) (0)
Reply to a. Molfino et Al. (2015) (0)
Late M edical C omplications a nd F atigue i n H odgkin's Disease S urvivors (2001) (0)
and on population : Results from an international Delphi process The European Association for Palliative Care basic dataset to describe a palliative care cancer (2014) (0)
Chapter 6 EU policy recommendations for quality improvement in cancer aftercare at the community level (2017) (0)
Brain metastases in Norway: A prospective cohort study. (2018) (0)
Causes for hospitalizing patients at a university hospital cancer clinic. (2014) (0)
Is transdermal buprenorphine for chronic non-malignant pain used long term without co-medication with other potentially addictive drugs? (2010) (0)
SECTION 4 The interdisciplinary team (2009) (0)
Automatic referral to standardize palliative care access (0)
MON-PP096: Changes in Plasma Levels of Omega-3 Pufas in Response to Supplementation with Omega-3 Pufa-Enriched Oral Nutritional Supplements in Advanced Cancer Patients (2015) (0)
[Terminal care sedation]. (1999) (0)
169 INVITED Recent research in opioid treated cancer pain (2007) (0)
[Palliative medicine]. (1997) (0)
282MO Brain metastases: Real-life treatment patterns, survival and patient-reported outcomes – Results from a population-based, prospective study in 914 patients (2022) (0)
Home death for children dying in six European countries (2009) (0)
10.1 The management of pain (2009) (0)
[Administration procedures in the treatment with cytostatics]. (1991) (0)
[Palliative medicine]. (2019) (0)
Reduction in tumor size after the first course of cisplatin/etoposide (PE) in limited disease small-cell lung cancer (LD SCLC). (2015) (0)
[Occurrence and diagnosis of psychiatric conditions in palliative medicine]. (2000) (0)
Quality of life and patient-reported outcome measures (2021) (0)
1392PCharacterization of cachectic patients with non-small cell lung cancer (NSCLC) according to their modified Glasgow Prognostic Score (mGPS) (2017) (0)
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation (1999) (0)
[Medullary compression in metastatic cancer]. (1999) (0)
[Good pain relief or euthanasia?]. (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stein Kaasa?

Stein Kaasa is affiliated with the following schools:

Karolinska Institute
Vrije Universiteit Brussel
University of Oslo
University of Bergen
Norwegian University of Science and Technology

Stein Kaasa's Academic­Influence.com Rankings

Why Is Stein Kaasa Influential?

Stein Kaasa's Published Works

Published Works

What Schools Are Affiliated With Stein Kaasa?

Stein Kaasa's AcademicInfluence.com Rankings